Background: Giant cell tumor (GCT) of bone is a rare and unpredictable lesion. Its standard treatment has ranged from surgical curettage to wide resection and varying oncological and functional results have been reported. Methods: A retrospective reviewof 47 patients(17 malesand 30 females) with GCT of bonewas performed to evaluate the oncological and functional results. The patients were followed up for at least 5 years. The average age of the patients was 32 years (range 15-66 years). The tumor sites were distal femur in 15 cases, proximal tibia in 10, distal radius in five, spinal column in four, proximal femur in three, proximal humerusin three, proximal fibula in two, pelvis in two and others in three. Enneking's surgicalstageswere Stage 1 in three, Stage 2 in 34 and Stage 3 in 10 cases. In these 47 patients, 80 surgical procedures were performed. Results: The rate of local recurrence was 75% in the 28 patients undergoing intralesional excision, 50% in those receiving excisionand curettage and 0% in those receiving wide resection. Although there was no statistical significance, surgical stages tended to be correlated with the local recurrence rate ( Conclusions: To preserve good function of the extremities and avoid local recurrence, we consider that intralesional excision with adjunctive therapy such as phenol cauterization should be employed for the treatment of benign GCT of bone.
INTRODUCTION
Giant cell tumor is an infrequent and unpredictable lesion (1-3). Other authors have generally failed to ascertain the biological or histological parameters that either determine the prognosis or indicate the best treatment (3-5). Enneking's surgical staging system (6) and Campanacci and co-workers' radiographic grading system (1,2) have provided better methods of evaluating and comparing the results of treatment. The standard treatment has ranged from surgical curettage to wide resection and varying results have been reported for all modalities (1,2,7-12). The purpose of this study was to evaluate the correlation between the surgical stage and the Received October 30, 1997; accepted February 3, 1998 For reprints and all correspondence: Yoshinao Oda, Department of Orthopaedic Surgery, Faculty of Medicine, Kyushu University, 1-1 Maidashi 3-chome, Higashi-ku, Fukuoka 812, Japan Abbreviations: GeT, giant cell tumor; MSTS, Musculoskeletal Tumor Society oncological or functional results of the treatment of giant cell tumor of bone at Kyushu University Hospital.
MATERIALS AND METHODS
At Kyushu University Hospital, 55 patients with giant cell tumor of bone were treated between 1963 and 1990. Six patients were followed up for less than 5 years and two patients died from other diseases. These eight patients were excluded from the study. The remaining 47 patients were followed up for at least 5 years. The average age at histological diagnosis was 32.2 years (range 15-66 years). The tumor sites were distal femur in 15 cases, proximal tibia in 10, distal radius in five, spinal column in four, proximal femur in three, proximal humerus in three, proximal fibula in two, pelvis in two and others in three. All the slides of biopsied and excised tumors were reviewed and the diagnoses were confirmed by one of the authors (M.T.), who is an experienced bone pathologist. Local recurrence was evaluated by the most recent radiogram or by interviewing the patients on the telephone or through a questionnaire. Prox., proximal; Dist., distal; fib., fibula; fern., femur; rad., radius; Great troch., greater trochanter; hum., humerus; tib., tibia; NA, not available; CDF, continuous disease free. *These scores denote pain, function and emotional acceptance, respectively. tThis patient had no local recurrence and received thoracotomy for lung metastasis.
OPERATING TECHNIQUE
Wide resection consisted of removal of the tumor and the adjacent involved bone as a unit, together with a wide margin. Reconstruction was individualized according to the age of the patient, the location of the tumor, the functional demands and the preference of the patient ( Fig. 1 and Table 1 ). Reconstruction was not performed in the two patients who had undergone a proximal fibular resection. For three patients with tumor of the distal radius, reconstruction by arthrodesis with fibular autograft was carried out. Excision and curettage (7) were performed in those cases where the tumor had occurred close to the joint surface. The tumorous lesions were removed by en blocresection with a wide margin for the most part, although the surgical margin would be intralesional (curettage) beneath the articular cartilage because of the need to preserve the joint function. The bone defect was packed with auto-or allograft.
Intralesional excision implies curettage. The tumor was exteriorized completely with a curette and the osseous surface of the tumor cavity was removed using a high-speed dental bar. The cavity was packed with either autogenous graft from iliac crest alone or mixed with allograft (Fig. 2) . Internal fixation was applied if indicated. Although we have been using phenol since 1992, neither phenol nor bone cement was used in this study.
SURGICAL STAGE
The surgical stage was determined according to the staging system of benign lesions of Enneking (6) (l , latent-always intracapsular, surrounded by mature cortical rim, remains static or heals spontaneously; 2, active-remains intracapsular, surrounded by thin but intact reactive bone which may be deformed; slowly expands; 3, locally aggressive--often extracapsular, not limited by reactive bone or by natural barriers). (MSTS) (13) . This system involves six factors for upper and lower extremities. Pain, function and emotional acceptance are factors for both upper and lower limbs. Support, walking ability A maximum of five points for each factor results in a maximum score of 30 points. Functional analysis was performed at the most recent follow-up visit. Functional evaluation was not available for three patients who received secondary amputation after local recurrence, four patients who suffered from a spinal column tumor, one patient who had died from multiple lung metastasis caused by malignant transformation of the primary tumor and eight patients who had refused or were unable to visit our clinic.
STATISTICAL ANALYSIS
As for oncological results, Kaplan-Meier product limit estimates of the disease-free ratio were generated for each group. Comparisons of the disease-free ratio between groups were performed using the log-rank. test. Concerning the comparisons of the functional results between each of the groups, an unpaired t-test or the Kruskal-Wallis test was applied. For all statistical analyses, a P value of <0.05 was considered significant.
RESULTS
Twenty-eight patients received intralesional eXCISIOn as their initial surgery, excision and curettage were carried out in six patients and wide resection was performed in 13 patients. In total, 80 surgical procedures were carried out on these 47 patients. Three cases were considered to be in Enneking's Stage 1, 34 cases in Stage 2 and 10 cases in Stage 3.
ONCOLOGICAL RESULTS
Twenty-one out of the 28 patients who underwent intralesional excision and three out of the six patients who received excision and curettage suffered local recurrence. There was no local recurrence in the group of patients receiving wide resection as their initial surgery. The recurrence rate of the patients undergoing intralesional excision and excision and curettage was 75 and 50%, respectively (Tables 2 and 3 ). Re-recurrences were observed in seven patients (25%) receiving intralesional excision and two patients (33%) receiving excision and curettage. The disease-free ratio of the patients treated with wide resection was significantly better than that of those treated with excision and curettage or intralesional excision (Fig. 3 , log-rank. test: P = malignant transformation of the initial tumor (3). Another patient with Stage 2 tumor received thoracotomy and the resultant histological diagnosis was 'benign pulmonary metastatic implants'.
FUNCTIONAL RESULTS

DISCUSSION
The function of the patients with a tumor of the distal radius tended to be better than that of those with tumors at other sites (distal radius, n = 4, 30 on average; distal femur, n = 9, 28.4 on average; proximal tibia, n = 6, 28.7 on average). However, there was no statistical difference between tumor sites according to functional evaluation.
In GCT, attempts to establish histological criteria for distinguishing indolent from aggressive tumors have identified no histological features. Campanacci and co-workers (1,2) and Enneking (6) have developed similar staging systems for GCTs. Campanacci's radiographic Grades I, II and III correspond to Enneking's surgical Stages 1,2 and 3, which represent the latent, active and aggressive clinical presentations, respectively. Experience with 327 patients at the Rizzoli Institute showed that there was no difference related to radiological grading with regard to treatment and prognosis and the only significant feature was the surgical margin (2). Present et al. (9) found no cellular atypia with Stage 3 tumors; however, the radiographically aggressive tumors demonstrated more aggressive features on histology. Moreover, they could not find any predictable features of recurrence or metastasis. McDonald et al. (8) and Giteris et al. (11) found no correlation between Campanacci's grading and local recurrence. In contrast, Rock (14) , in a multi-institutional study, found a weak correlation between Campanacci's and Enneking's stages and the rate of local recurrence. In this study, we employed Enneking's surgical stage and it seemed to be correlated with a higher recurrence rate, although there was no statistical difference. This may reflect the results of simple curettage and bone graft (intralesional excision) without any adjunctive therapy, such as phenol and acid alcohol, liquid-nitrogen cryosurgery and methyl methacrylate therapy in our series. The above-mentioned authors employed adjuvant therapy in the group of patients treated with curettage. In our series, two patients with Stage 3 tumors and one with a Stage 2 tumor received secondary amputation after initial intralesional excision and all six Stage 3 cases with intralesional excision suffered local recurrence. 0.001). Ofthe 24 patients who suffered with local recurrences, 15 (63 %) had only one recurrence, seven (29% ) had two recurrences and two (8%) suffered recurrences three times. The interval between surgery and local recurrence in the patients who underwent intralesional excision ranged from 3 to 90 months (average 24.9 months) postoperatively. Three of the patients treated with excision and curettage had recurrence 15, 17 and 37 months after surgery. Eight patients (33%) had recurrence more than 2 years after surgery while two patients suffered recurrence more than 5 years after surgery. Of the 28 patients who were treated by intralesional excision, 14 (50%) remained free of disease for more than 2 years.
Surgical stages tended to be correlated with a high recurrence rate (Stage 1, 0%; Stage 2, 53%; Stage 3, 70%). However, there was no statistical significance in these three groups (Fig. 4, log-rank test P = 0.105). A secondary amputation was performed in two patients with Stage 3 tumors and in one patient with a Stage 2 tumor. Two patients developed lung metastases. One patient with a Stage 3 tumor died of multiple lung metastasis after Dist., distal; Prox., proximal; fern., femur; rad., radius; tib., tibia; NA, not available; M, months; EC, excision and curettage; IE, intralesional excision. Campanacci et al. (2) reported that their recurrence rate was 27% after intralesional excision, 7% after marginal excision and zero after wide excision. Sung et al. (7) reported in their review of 111 cases a recurrence rate of 41% following curettage and bone grafting and 7.1% after en bloc resection, during a follow-up period of at least 2 years. In our series, the recurrence rate was 75% after curettage and simple bone grafting (intralesional excision), 50% after excision and curettage and zero after wide resection, during a follow-up period of at least 5 years. The rate of local recurrence in our study was much higher than those reported in the literature. The reason for this discrepancy may be the lack of adjuvant therapy for the patients who received intralesional excision and excision and curettage. Giteris et al.
(11) performed intralesional excision combined with adjunctive local application of an agent such as phenol or methyl methacrylate and only one of 20 patients with intralesional excision suffered local recurrence. On the other hand, we did not use these agents in this study. Therefore, we considered that the adjunctive therapy should be performed in the patients who received intralesional excision to avoid local recurrence. In fact, we have been using phenol since 1992.
The great majority of recurrences occurred within 2 years. Sixteen out of 24 patients (67%) suffered local recurrence within the first 2 years, six (25%) suffered recurrence between 2 and 5 years later and two (8.3%) suffered recurrence more than 5 years later. Therefore, postoperative follow-up examinations of GCT patients are essential for at least the first 5 years, as recommended by Eckardt and Grogan (15) .
McDonald et al. (8) reported that re-recurrence was observed in 15 patients (20%) out of 75 recurrent cases. Further recurrence had occurred in seven patients (9.3%). In our series, re-recurrence was observed in nine patients (37.5%) out of 24 recurrent cases. Further recurrence occurred in two patients (8.3%). No patients suffered more than three recurrences. There is a possibility that benign GCTs might heal after a several recurrences in their natural course.
The most recent MSTS functional evaluation system was published in 1993 by Enneking et al. (13) . The system had a small interobserver variability and proved simple in use for the functional evaluation of a group of 220 patients after surgery for bone and soft tissue tumors. A high surgical stage was correlated with poor functional results in our series. This may be due to the frequent surgical procedures needed owing to the frequent recurrence of high-stage tumors. As for the location, patients with tumors of the distal radius demonstrated good functional results, as reported by Campbell and Akbarnia (16) . Giteris et al. (11) employed this system and reported improved functional results after the intralesional procedure than following the en bloc resection. Rooney et al. (10) reported the successful preservation of the involved joint and a reduction of the local recurrence by modified intralesional excision in grade III GCT. In the current study, we could not find any statistically significant difference between the groups of surgical procedures regarding the functional results. However, the functional results for the patients undergoing intralesional excision (average 28.2) or excision and curettage (average 30) seemed to be better than those of the patients undergoing wide resection (average 27.1), in spite of the frequent local recurrences and the necessity for additional surgical procedures in these patient groups. Therefore, we consider that the minimum surgical procedure such as intralesional excision should be carried out to preserve the joint function and good functional results in GCT of bone.
